ClinicalTrials.govpublic full text
Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
diabetes mellitus, type 2, atherosclerosis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 391078
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.